Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes
- 24 March 2020
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 38 (16) , 1807-1813
Abstract
PURPOSE: Recently developed clinical guidelines suggest that men in families with specific cancer syndromes, such as hereditary breast and ovarian cancer (HBOC), consider genetic testing, especially in the setting of aggressive disease. However, although a family history (FH) of the same disease among close relatives is an established risk factor for prostate cancer (PC), a direct comparison of PC risk for men with each syndrome in a single population is needed. METHODS: The Utah Population Database was used to identify 619,630 men, age ≥ 40 years, who were members of a pedigree that included at least 3 consecutive generations. Each man was evaluated for FH of hereditary PC (HPC), HBOC, and Lynch syndrome (LS) and for his own PC status. PC occurrences (N = 36,360) were classified into one or more subtypes: early onset (EO), lethal, and/or clinically significant. Relative risks (RRs) associated with each subtype, adjusted for important covariables, were calculated in STATA using a modified Poisson regression with robust error variances to obtain corresponding RR CIs for each FH definition. RESULTS: An FH of HPC conveyed the greatest relative risk for all PC subtypes combined (RR, 2.30; 95% CI, 2.22 to 2.40), followed by HBOC and LS (both with 1 < RR < 2 and statistically significant). The strongest risks associated with FH were observed for EO disease in all pedigree types, consistent with the contribution of genetic factors to disease occurrence. CONCLUSION: In this large, population-based, family database, the risk of PC varied by cancer FH and was most strongly associated with EO disease. These results are critically valuable in understanding and targeting high-risk populations that would benefit from genetic screening and enhanced surveillance.Keywords
This publication has 39 references indexed in Scilit:
- Prostate cancer incidence in males with Lynch syndromeGenetics in Medicine, 2014
- G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysisTumor Biology, 2013
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping arrayNature Genetics, 2013
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)Human Genetics, 2012
- The role of BRCA1 and BRCA2 in prostate cancerAsian Journal of Andrology, 2012
- Germline Mutations inHOXB13and Prostate-Cancer RiskNew England Journal of Medicine, 2012
- An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-AnalysisPLOS ONE, 2011
- Hereditary prostate cancer as a feature of Lynch SyndromeFamilial Cancer, 2010
- Rapid progression of prostate cancer in men with a BRCA2 mutationBritish Journal of Cancer, 2008
- Familial Prostate CancerEpidemiologic Reviews, 2001